Evolving treatment paradigms of cerebral aneurysm stasis in flow diversion

IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Journal of Clinical Neuroscience Pub Date : 2025-02-01 DOI:10.1016/j.jocn.2024.110996
Joshua H. Weinberg , Max Gruber , Nathan Ritchey, Landon Ehlers, Santino Cua, Amanda Zakeri, Ciaran Powers, Shahid Nimjee, Patrick Youssef
{"title":"Evolving treatment paradigms of cerebral aneurysm stasis in flow diversion","authors":"Joshua H. Weinberg ,&nbsp;Max Gruber ,&nbsp;Nathan Ritchey,&nbsp;Landon Ehlers,&nbsp;Santino Cua,&nbsp;Amanda Zakeri,&nbsp;Ciaran Powers,&nbsp;Shahid Nimjee,&nbsp;Patrick Youssef","doi":"10.1016/j.jocn.2024.110996","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Flow diversion is an effective first-line treatment for intracranial aneurysms; however, the rate of incomplete occlusion is not insignificant. Data in neuroendovascular literature is limited regarding the implications of persistent incomplete occlusion despite flow diversion.</div></div><div><h3>Methods</h3><div>We conducted a retrospective analysis of a prospectively maintained database and identified 125 consecutive patients with treatment naïve intracranial aneurysms who underwent flow diversion with the PED from April 2014 − November 2022. Patients were divided into 3 groups based on the duration of stasis: venous, capillary, and no stasis. Comparative and multivariate analyses were performed between the three groups.</div></div><div><h3>Results</h3><div>At latest follow-up, complete occlusion occurred in 69.6 % and 82.4 % showed progression of occlusion. Retreatment was required in 2.4 %. There was no significant difference in retreatment (<em>p</em> = 0.667), complete occlusion (<em>p</em> = 0.774) or progression of occlusion (<em>p</em> = 0.848) at latest follow up. No patients experienced subarachnoid hemorrhage post-treatment. On multivariate analysis, hypertension was a negative predictor for complete occlusion (p = 0.006) and progression of occlusion (p = 0.017), while duration of stasis was noncontributory. The mean latest follow up was 12.55 months.</div></div><div><h3>Conclusion</h3><div>Flow diversion is a safe and effective first line treatment for intracranial aneurysms with a relatively low complication rate. Hypertension was a negative predictor of complete occlusion and progression of occlusion, while the degree of occlusion post-flow diversion may not be predictive of future rupture risk and the Raymond Roy Occlusion classification may not apply. The degree of stasis after initial treatment was not predictive of future occlusion, retreatment, nor aneurysm rupture risk. However, stasis degree may be worth additional analysis given this studies sample size, lack of long-term follow-up, and the lack of predictive factors in current literature to guide post-flow diversion management.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"132 ","pages":"Article 110996"},"PeriodicalIF":1.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0967586824005356","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Flow diversion is an effective first-line treatment for intracranial aneurysms; however, the rate of incomplete occlusion is not insignificant. Data in neuroendovascular literature is limited regarding the implications of persistent incomplete occlusion despite flow diversion.

Methods

We conducted a retrospective analysis of a prospectively maintained database and identified 125 consecutive patients with treatment naïve intracranial aneurysms who underwent flow diversion with the PED from April 2014 − November 2022. Patients were divided into 3 groups based on the duration of stasis: venous, capillary, and no stasis. Comparative and multivariate analyses were performed between the three groups.

Results

At latest follow-up, complete occlusion occurred in 69.6 % and 82.4 % showed progression of occlusion. Retreatment was required in 2.4 %. There was no significant difference in retreatment (p = 0.667), complete occlusion (p = 0.774) or progression of occlusion (p = 0.848) at latest follow up. No patients experienced subarachnoid hemorrhage post-treatment. On multivariate analysis, hypertension was a negative predictor for complete occlusion (p = 0.006) and progression of occlusion (p = 0.017), while duration of stasis was noncontributory. The mean latest follow up was 12.55 months.

Conclusion

Flow diversion is a safe and effective first line treatment for intracranial aneurysms with a relatively low complication rate. Hypertension was a negative predictor of complete occlusion and progression of occlusion, while the degree of occlusion post-flow diversion may not be predictive of future rupture risk and the Raymond Roy Occlusion classification may not apply. The degree of stasis after initial treatment was not predictive of future occlusion, retreatment, nor aneurysm rupture risk. However, stasis degree may be worth additional analysis given this studies sample size, lack of long-term follow-up, and the lack of predictive factors in current literature to guide post-flow diversion management.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血流转移中脑动脉瘤淤滞治疗模式的演变。
导言:分流是治疗颅内动脉瘤的有效一线治疗方法;然而,不完全闭塞率并非微不足道。尽管血流转移,但神经血管内文献中关于持续不完全闭塞的影响的数据有限。方法:我们对前瞻性维护的数据库进行了回顾性分析,并确定了2014年4月至2022年11月期间125例连续接受PED分流治疗naïve颅内动脉瘤患者。根据瘀血持续时间将患者分为静脉、毛细血管、无瘀血3组。对三组患者进行比较分析和多变量分析。结果:最近一次随访时,69.6%的患者完全咬合,82.4%的患者咬合进展。需要再治疗的占2.4%。最后随访时两组再治疗(p = 0.667)、完全咬合(p = 0.774)和咬合进展(p = 0.848)无显著差异。治疗后无蛛网膜下腔出血。在多变量分析中,高血压是完全闭塞(p = 0.006)和闭塞进展(p = 0.017)的负相关预测因子,而停滞期的持续时间则不是影响因素。平均最新随访时间为12.55个月。结论:分流术是治疗颅内动脉瘤安全有效的一线治疗方法,并发症发生率较低。高血压是完全闭塞和闭塞进展的负预测因子,而血流转移后的闭塞程度可能不能预测未来的破裂风险,雷蒙德罗伊闭塞分类可能不适用。初始治疗后的停滞程度不能预测未来的闭塞、再治疗或动脉瘤破裂的风险。然而,鉴于本研究的样本量,缺乏长期随访,以及目前文献中缺乏指导分流后管理的预测因素,停滞程度可能值得进一步分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Clinical Neuroscience
Journal of Clinical Neuroscience 医学-临床神经学
CiteScore
4.50
自引率
0.00%
发文量
402
审稿时长
40 days
期刊介绍: This International journal, Journal of Clinical Neuroscience, publishes articles on clinical neurosurgery and neurology and the related neurosciences such as neuro-pathology, neuro-radiology, neuro-ophthalmology and neuro-physiology. The journal has a broad International perspective, and emphasises the advances occurring in Asia, the Pacific Rim region, Europe and North America. The Journal acts as a focus for publication of major clinical and laboratory research, as well as publishing solicited manuscripts on specific subjects from experts, case reports and other information of interest to clinicians working in the clinical neurosciences.
期刊最新文献
Acute Progressive Frozen Eye in a Young Male Current and future clinical trials for the use of neuromodulation in the treatment of stroke: A review of the clinical Trials.gov database Risk factors for residual dizziness after successful repositioning in elderly patients with benign paroxysmal positional vertigo Clinical and imaging features and treatment response of anti-NMDAR encephalitis combined with MOGAD Validation of the Korean version of the Bad Sobernheim stress Questionnaire-Brace in adolescent idiopathic scoliosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1